ATE160503T1 - Verwendung von bestimmten aniontensiden zur erhöhung der antimikrobenwirkung von ophthalmischen zusammensetzungen - Google Patents

Verwendung von bestimmten aniontensiden zur erhöhung der antimikrobenwirkung von ophthalmischen zusammensetzungen

Info

Publication number
ATE160503T1
ATE160503T1 AT93306656T AT93306656T ATE160503T1 AT E160503 T1 ATE160503 T1 AT E160503T1 AT 93306656 T AT93306656 T AT 93306656T AT 93306656 T AT93306656 T AT 93306656T AT E160503 T1 ATE160503 T1 AT E160503T1
Authority
AT
Austria
Prior art keywords
anionic surfactants
ophthalmic compositions
increase
certain anionic
antimicrobic
Prior art date
Application number
AT93306656T
Other languages
English (en)
Inventor
Ernest J Castillo
Yusuf Ali
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Application granted granted Critical
Publication of ATE160503T1 publication Critical patent/ATE160503T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT93306656T 1992-08-28 1993-08-23 Verwendung von bestimmten aniontensiden zur erhöhung der antimikrobenwirkung von ophthalmischen zusammensetzungen ATE160503T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93722892A 1992-08-28 1992-08-28

Publications (1)

Publication Number Publication Date
ATE160503T1 true ATE160503T1 (de) 1997-12-15

Family

ID=25469650

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93306656T ATE160503T1 (de) 1992-08-28 1993-08-23 Verwendung von bestimmten aniontensiden zur erhöhung der antimikrobenwirkung von ophthalmischen zusammensetzungen

Country Status (9)

Country Link
EP (1) EP0590786B1 (de)
JP (1) JP2594877B2 (de)
AT (1) ATE160503T1 (de)
AU (1) AU666957B2 (de)
DE (1) DE69315406T2 (de)
DK (1) DK0590786T3 (de)
ES (1) ES2111717T3 (de)
GR (1) GR3025769T3 (de)
MX (1) MX9305230A (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554367A (en) * 1984-10-31 1996-09-10 Alcon Laboratories, Inc. Compositions for treatment of glaucoma
AU671374B2 (en) * 1993-08-13 1996-08-22 Alcon Laboratories, Inc. Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions
JP2001504100A (ja) * 1996-11-01 2001-03-27 アルコン・ラボラトリーズ・インコーポレーテッド 緑内障を治療するための炭酸脱水素酵素阻害剤とプロスタグランジンとの組合せの使用
EP1024810A4 (de) * 1997-06-26 2003-06-11 Merck & Co Inc Verfahren zur optimierung von retinal und der gesundheit des optischen nerves
US6645963B2 (en) 1997-11-05 2003-11-11 Senju Pharmaceutical Co., Ltd. Prolonged-action eye drop
CN1124842C (zh) * 1997-11-05 2003-10-22 千寿制药株式会社 缓释滴眼剂
EP0938896A1 (de) * 1998-01-15 1999-09-01 Novartis AG In Autoklaven behandelbare pharmazeutische Zusammensetzungen mit Komplexbildner
WO2000001365A1 (en) * 1998-06-30 2000-01-13 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) Prolonged release ophthalmic compositions containing a fluoroquinolone
US6211238B1 (en) * 1998-10-27 2001-04-03 Alcon Laboratories, Inc. Preservative system for topically administrable pharmaceutical compositions
US20020176842A1 (en) * 2001-04-09 2002-11-28 Lyn Hughes Extended release of active ingredients
US7045121B2 (en) * 2001-12-14 2006-05-16 Allergan, Inc. Ophthalmic compositions for lubricating eyes and methods for making and using same
BRPI0408109A (pt) * 2003-03-05 2006-03-01 Rhodia composição limpadora de superfìcie rìgida aquosa e método para limpar uma superfìcie dura
DE602004023516D1 (de) 2003-08-07 2009-11-19 Allergan Inc Zusammensetzungen zur abgabe von therapeutika in die augen und verfahren zu ihrer herstellung und verwendung
US7678578B2 (en) * 2005-02-07 2010-03-16 Beckman Coulter, Inc. Cell permeabilization and stabilization reagent and method of use
US9192571B2 (en) 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
US7842714B2 (en) 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
JP5870459B2 (ja) * 2010-08-27 2016-03-01 わかもと製薬株式会社 点眼用水性組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3275503A (en) * 1964-08-26 1966-09-27 Patterson Co C Method for the protection of loci susceptible to the growth of undesired microorganisms
US4911920A (en) 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
CA1302280C (en) * 1986-04-21 1992-06-02 Jon Joseph Kabara Topical antimicrobial pharmaceutical compositions and methods

Also Published As

Publication number Publication date
DE69315406D1 (de) 1998-01-08
EP0590786B1 (de) 1997-11-26
MX9305230A (es) 1994-02-28
DE69315406T2 (de) 1998-03-19
HK1004773A1 (en) 1998-12-04
ES2111717T3 (es) 1998-03-16
AU666957B2 (en) 1996-02-29
EP0590786A1 (de) 1994-04-06
GR3025769T3 (en) 1998-03-31
AU4440193A (en) 1994-03-03
DK0590786T3 (da) 1998-08-10
JPH06211694A (ja) 1994-08-02
JP2594877B2 (ja) 1997-03-26

Similar Documents

Publication Publication Date Title
DE69315406D1 (de) Verwendung von bestimmten Aniontensiden zur Erhöhung der Antimikrobenwirkung von ophthalmischen Zusammensetzungen
CA2104917A1 (en) Use of Certain Anionic Surfactants to Enhance Antimicrobial Effectiveness of Ophthalmic Compositions
DE69427704D1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n-disubstituierte-amino-3,4-dihydro-2h-1-benzopyrane
MX9203653A (es) Composiciones amfotericas y formas polimericas de los alfa-hidroxiacidos.
SV1994000028A (es) Nuevas sulfonilamino pirimidinas, ref. 10916 sv.
DE69917285D1 (de) Stabilisierte zusammensetzungen mit antibakterieller wirksamkeit
MX9306735A (es) Nuevos agentes antimicrobianos polimericos y su uso en composiones farmaceuticas.
DE69106493D1 (de) Sulfonische Stilbenderivate zur Behandlung von Viruserkrankungen.
CO5070657A1 (es) Composiciones farmaceuticas para tratar infecciones virales y metodo para hacerlas
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
ATE242220T1 (de) Benzimidazolderivate mit dopaminerger wirkung
ES2158094T3 (es) Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina.
ATE10255T1 (de) Pharmazeutische mischung.
FI910112A0 (fi) Preparat foer lokalt bruk.
ATE102435T1 (de) Mikrobiozide zusammensetzungen.
DK0617035T3 (da) Hetero-tricyclisk-substituerede phenyl-cyclohexan-carboxylsyrederivater.
TR200200724T2 (tr) Cilde sürülebilen farmasötik bileşimlerin antimikrobik etkisinin arttırılması için yağlı asit/amino asit sabunlarının kullanımı
ATE132877T1 (de) Emulgatorfreie emulsionspolymere in pharmazeutischen zubereitungen mit verzögerter wirkstofffreigabe und ihre herstellung
DE69632682D1 (de) Bekämpfung von schadinsekten
DK643289A (da) Substituerede guanidin- og amidinforbindelser, fremgangsmaade til fremstilling deraf samt deres anvendelse som fungicider
ATE237595T1 (de) Substituierte phenyluracile mit herbizider wirkung
DE69505277D1 (de) Dermato-kosmetologisches präparat
ES2166495T3 (es) Derivados de difluorclorometioxibenceno y su empleo como agentes pesticidas.
UA25538C2 (uk) Протипаразитарний та антимікробний лікарський засіб для місцевого застосування

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification